High incidence rate of vertebral fractures during chronic prednisone treatment, in spite of bisphosphonate or alfacalcidol use. Extension of the "Alendronate or alfacalcidol in glucocorticoid-induced osteoporosis"-trial

J.N. Hoes; J.W. Jacobs; H.M. Hulsman; R.N. de Nijs; W.F. Lems; G.A. Bruyn; P.P. Geusens; J.W. Bijlsma

High incidence rate of vertebral fractures during chronic prednisone treatment, in spite of bisphosphonate or alfacalcidol use. Extension of the "Alendronate or alfacalcidol in glucocorticoid-induced osteoporosis"-trial

J.N. Hoes, J.W. Jacobs, H.M. Hulsman, R.N. de Nijs, W.F. Lems, G.A. Bruyn, P.P. Geusens, J.W. Bijlsma

Rheumatology

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	354-349
Journal	Clinical and Experimental Rheumatology
Volume	28
Issue number	3
Publication status	Published - 2010

Cite this

Hoes, J. N., Jacobs, J. W., Hulsman, H. M., de Nijs, R. N., Lems, W. F., Bruyn, G. A., Geusens, P. P., & Bijlsma, J. W. (2010). High incidence rate of vertebral fractures during chronic prednisone treatment, in spite of bisphosphonate or alfacalcidol use. Extension of the "Alendronate or alfacalcidol in glucocorticoid-induced osteoporosis"-trial. Clinical and Experimental Rheumatology, 28(3), 354-349.

Hoes, J.N. ; Jacobs, J.W. ; Hulsman, H.M. ; de Nijs, R.N. ; Lems, W.F. ; Bruyn, G.A. ; Geusens, P.P. ; Bijlsma, J.W. / High incidence rate of vertebral fractures during chronic prednisone treatment, in spite of bisphosphonate or alfacalcidol use. Extension of the "Alendronate or alfacalcidol in glucocorticoid-induced osteoporosis"-trial. In: Clinical and Experimental Rheumatology. 2010 ; Vol. 28, No. 3. pp. 354-349.

@article{af54aa289c444d4f8d63e62000845cae,

title = "High incidence rate of vertebral fractures during chronic prednisone treatment, in spite of bisphosphonate or alfacalcidol use. Extension of the {"}Alendronate or alfacalcidol in glucocorticoid-induced osteoporosis{"}-trial",

author = "J.N. Hoes and J.W. Jacobs and H.M. Hulsman and {de Nijs}, R.N. and W.F. Lems and G.A. Bruyn and P.P. Geusens and J.W. Bijlsma",

year = "2010",

language = "Undefined/Unknown",

volume = "28",

pages = "354--349",

journal = "Clinical and Experimental Rheumatology",

issn = "0392-856X",

publisher = "Clinical and Experimental Rheumatology S.A.S.",

number = "3",

}

Hoes, JN, Jacobs, JW, Hulsman, HM, de Nijs, RN, Lems, WF, Bruyn, GA, Geusens, PP & Bijlsma, JW 2010, 'High incidence rate of vertebral fractures during chronic prednisone treatment, in spite of bisphosphonate or alfacalcidol use. Extension of the "Alendronate or alfacalcidol in glucocorticoid-induced osteoporosis"-trial', Clinical and Experimental Rheumatology, vol. 28, no. 3, pp. 354-349.

High incidence rate of vertebral fractures during chronic prednisone treatment, in spite of bisphosphonate or alfacalcidol use. Extension of the "Alendronate or alfacalcidol in glucocorticoid-induced osteoporosis"-trial. / Hoes, J.N.; Jacobs, J.W.; Hulsman, H.M.; de Nijs, R.N.; Lems, W.F.; Bruyn, G.A.; Geusens, P.P.; Bijlsma, J.W.

In: Clinical and Experimental Rheumatology, Vol. 28, No. 3, 2010, p. 354-349.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - High incidence rate of vertebral fractures during chronic prednisone treatment, in spite of bisphosphonate or alfacalcidol use. Extension of the "Alendronate or alfacalcidol in glucocorticoid-induced osteoporosis"-trial

AU - Hoes, J.N.

AU - Jacobs, J.W.

AU - Hulsman, H.M.

AU - de Nijs, R.N.

AU - Lems, W.F.

AU - Bruyn, G.A.

AU - Geusens, P.P.

AU - Bijlsma, J.W.

PY - 2010

Y1 - 2010

M3 - Article

VL - 28

SP - 354

EP - 349

JO - Clinical and Experimental Rheumatology

JF - Clinical and Experimental Rheumatology

SN - 0392-856X

IS - 3

ER -